Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation.

Autor: Lu W; Department of Hematology, Institute of Hematology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Lyu H; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Xiao X; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Bai X; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Zhang M; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China.; Department of Hematology, Beijing Children's Hospital, Beijing, China., Wang J; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Pu Y; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Meng J; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Zhang X; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Zhu H; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Yuan T; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Wang B; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Jin X; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Cao X; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Wang Z; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Xie T; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Meng H; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Stepanov AV; M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., Gabibov AG; M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia., An Y; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Sun R; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Zhang Y; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China., Maschan MA; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Zhu Z; Department of Hematology, Institute of Hematology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China. zhuzm1964@163.com., Zhang H; State Key Laboratory of Medicinal Chemical Biology and College of Life Science, Nankai University, Tianjin, China. hongkai@nankai.edu.cn., Zhao M; Department of Hematology, Tianjin First Central Hospital, Tianjin, China. mingfengzhao@sina.com.; Department of Hematology, Nankai University Affiliated First Central Hospital, Tianjin, China. mingfengzhao@sina.com.
Jazyk: angličtina
Zdroj: Leukemia [Leukemia] 2024 Jun; Vol. 38 (6), pp. 1419-1422. Date of Electronic Publication: 2024 Apr 17.
DOI: 10.1038/s41375-024-02251-5
Databáze: MEDLINE